GOLM1 and Hepatic fibrosis: The strategies combining GP73 with other biomarkers could improve its diagnostic accuracy in identifying advanced fibrosis and provide precise information about liver fibrosis stage, but further studies are needed to establish its position in an algorithm (triage, add-on, or replacement) and to confirm the clinical relevance of this biomarker.